Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix and Prevenar13 Co-administration Study
NCT03439657Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2018
- Primary completion
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Apr 2018; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03439657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439657.